Masimo Corp. (NASDAQ:MASI) EVP Yongsam Lee sold 30,000 shares of Masimo Corp. stock in a transaction dated Monday, October 10th. The stock was sold at an average price of $60.50, for a total value of $1,815,000.00. Following the sale, the executive vice president now directly owns 93,000 shares of the company’s stock, valued at approximately $5,626,500. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Masimo Corp. (NASDAQ:MASI) opened at 58.92 on Thursday. Masimo Corp. has a 1-year low of $33.03 and a 1-year high of $60.81. The stock has a market cap of $2.91 billion, a price-to-earnings ratio of 30.90 and a beta of 0.70. The firm’s 50 day moving average price is $59.19 and its 200-day moving average price is $51.89.

Masimo Corp. (NASDAQ:MASI) last announced its earnings results on Wednesday, August 3rd. The company reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.41 by $0.16. Masimo Corp. had a net margin of 15.40% and a return on equity of 29.07%. The business earned $172.64 million during the quarter, compared to the consensus estimate of $166.02 million. During the same quarter in the prior year, the firm earned $0.36 earnings per share. The business’s quarterly revenue was up 10.9% compared to the same quarter last year. On average, equities analysts anticipate that Masimo Corp. will post $2.02 earnings per share for the current year.

Insider Buying and Selling by Quarter for Masimo Corp. (NASDAQ:MASI)

Several large investors have recently made changes to their positions in MASI. PineBridge Investments L.P. increased its stake in shares of Masimo Corp. by 2.7% in the second quarter. PineBridge Investments L.P. now owns 5,591 shares of the company’s stock valued at $293,000 after buying an additional 149 shares during the period. Los Angeles Capital Management & Equity Research Inc. increased its stake in shares of Masimo Corp. by 0.7% in the first quarter. Los Angeles Capital Management & Equity Research Inc. now owns 56,685 shares of the company’s stock valued at $2,372,000 after buying an additional 400 shares during the period. Teachers Advisors Inc. increased its stake in shares of Masimo Corp. by 0.7% in the second quarter. Teachers Advisors Inc. now owns 65,736 shares of the company’s stock valued at $3,452,000 after buying an additional 460 shares during the period. UBS Asset Management Americas Inc. increased its stake in shares of Masimo Corp. by 1.6% in the second quarter. UBS Asset Management Americas Inc. now owns 28,855 shares of the company’s stock valued at $1,515,000 after buying an additional 467 shares during the period. Finally, UBS Group AG increased its stake in shares of Masimo Corp. by 3.6% in the first quarter. UBS Group AG now owns 19,177 shares of the company’s stock valued at $802,000 after buying an additional 663 shares during the period. Institutional investors and hedge funds own 79.88% of the company’s stock.

A number of analysts have commented on the company. Zacks Investment Research cut Masimo Corp. from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 4th. Piper Jaffray Cos. reiterated an “overweight” rating and set a $55.00 price objective (up previously from $52.00) on shares of Masimo Corp. in a research note on Friday, August 5th. BTIG Research reiterated a “hold” rating on shares of Masimo Corp. in a research note on Friday, August 5th. Finally, Wedbush reiterated an “outperform” rating and set a $63.00 price objective (up previously from $60.00) on shares of Masimo Corp. in a research note on Thursday, August 4th. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $52.60.

Masimo Corp. Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products. The Company’s business is measure-through-motion and low-perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include monitoring blood constituents with an optical signature, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and exhaled gas monitoring.

5 Day Chart for NASDAQ:MASI

Receive News & Stock Ratings for Masimo Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corp. and related stocks with our FREE daily email newsletter.